A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis - Concepedia

Concepedia

Publication | Open Access

A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis

DOI Full Paper Access

113

Citations

30

References

2015

Year

Richard N. Greenberg, Yadira Hurley, Dinh V. Dinh, Serena Mraz, Javier Goméz Vera, Dorothea von Bredow, Alfred von Krempelhuber, Siegfried Röesch, Garth Virgin, Nathaly Arndtz-Wiedemann,

Abstract

ClinicalTrials.gov NCT00316602.

References

	Year	Citations

Page 1